XNCR now quite visible: Credite Suisse, Wedburth, and Leering Swan just started covering it, rating it Ouperform. Great news, stock shooting up! Now fer sure smart money to follow! GO, XNCR, GO, GO, GO!
And now for my non-pro thoughts, free of course!:
All IPOs regardless of industry are touted to high heaven. Pharmas/biotechs IPOs well known to take years before products ready for market---research, testing, more research, further testing, FDA approval (hopefully!). The science/research involved and partnerships create the initial hoopla, which may or may not propel the stock price. I'll patiently wait....
My only concern is any IPO for a pharmaceutical companies are usually made out to look really promising with strong upside in the near term. Most pharmaceutical companies tend to pull down a lot from the IPO's.